Literature DB >> 17598132

[Therapy of chronic ischemic pain in peripheral arterial disease. A survey among physicians].

L J Rüger1, D Irnich, S Grasmueller, P M Lang.   

Abstract

BACKGROUND: The intention of this study was to determine the status quo of commonly used pain therapies amongst treating physicians of different specialties and to examine their view on the problem of chronic ischemic pain.
METHODS: A total of 281 physicians treating patients with chronic ischemic pain were surveyed. The surveyed physicians were mainly specialists in the fields of surgery, pain therapy, and internal medicine.
RESULTS: Mainly a pharmacological therapy (metamizol/paracetamol, weak and strong opioids) was used in the treatment of chronic ischemic pain. We found differences between the specialties, for instance pain specialists used antidepressants and anticonvulsants more often than others. Therapeutic options were also evaluated differently by surgeons, pain therapists, and internal specialists: 57% of the surgeons considered the available symptomatic treatment options as sufficient whereas only 21% of the pain specialists agreed with that opinion.
CONCLUSION: The differences among the specialties and the fact that the majority of physicians characterized the available symptomatic treatment options as insufficient point towards a need to review the treatment of ischemic pain in an interdisciplinary approach.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17598132     DOI: 10.1007/s00482-007-0556-1

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  16 in total

Review 1.  ABC of arterial and venous disease: Chronic lower limb ischaemia.

Authors:  J D Beard
Journal:  BMJ       Date:  2000-03-25

Review 2.  [Pain in chronic peripheral arterial occlusive disease. Pathogenesis and therapy].

Authors:  H Rieger; A Scheffler
Journal:  Internist (Berl)       Date:  1999-02       Impact factor: 0.743

Review 3.  Second European Consensus Document on chronic critical leg ischemia.

Authors: 
Journal:  Circulation       Date:  1991-11       Impact factor: 29.690

Review 4.  The results of spinal cord stimulation in critical limb ischaemia: a review.

Authors:  G H Spincemaille; H C de Vet; D T Ubbink; M J Jacobs
Journal:  Eur J Vasc Endovasc Surg       Date:  2001-02       Impact factor: 7.069

Review 5.  Spinal cord stimulation for critical leg ischemia: a review of effectiveness and optimal patient selection.

Authors:  Dirk Th Ubbink; Hester Vermeulen
Journal:  J Pain Symptom Manage       Date:  2006-04       Impact factor: 3.612

6.  Peripheral neuropathy associated with ischemic vascular disease of the lower limbs.

Authors:  F Laghi Pasini; M Pastorelli; U Beermann; S de Candia; S Gallo; P Blardi; T Di Perri
Journal:  Angiology       Date:  1996-06       Impact factor: 3.619

7.  Sensory neuropathy and signs of central sensitization in patients with peripheral arterial disease.

Authors:  Philip M Lang; Gabriel M Schober; Roman Rolke; Susanne Wagner; Robert Hilge; Martin Offenbächer; Rolf-Detlef Treede; Ulrich Hoffmann; Dominik Irnich
Journal:  Pain       Date:  2006-05-22       Impact factor: 6.961

8.  Progression of neuropathy in peripheral arterial disease.

Authors:  J D England; M A Ferguson; W R Hiatt; J G Regensteiner
Journal:  Muscle Nerve       Date:  1995-04       Impact factor: 3.217

9.  Axonal neuropathy in chronic peripheral arterial occlusive disease.

Authors:  Frank Weber; Andrea Ziegler
Journal:  Muscle Nerve       Date:  2002-10       Impact factor: 3.217

Review 10.  Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia.

Authors:  D T Ubbink; H Vermeulen
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20
View more
  2 in total

1.  [Repeated percutaneous chemical sympathectomy as a therapeutic option for treating PAD II].

Authors:  P Gaus; M Grabener; W Höche; P Saur
Journal:  Schmerz       Date:  2010-12       Impact factor: 1.107

Review 2.  Pain Management in People with Diabetes-Related Chronic Limb-Threatening Ischemia.

Authors:  Xiaoyan Jiang; Yi Yuan; Yu Ma; Miao Zhong; Chenzhen Du; Johnson Boey; David G Armstrong; Wuquan Deng; Xiaodong Duan
Journal:  J Diabetes Res       Date:  2021-05-08       Impact factor: 4.061

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.